{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T10:44:02Z","timestamp":1774262642550,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,6,24]],"date-time":"2015-06-24T00:00:00Z","timestamp":1435104000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s12094-015-1325-8","type":"journal-article","created":{"date-parts":[[2015,6,23]],"date-time":"2015-06-23T05:11:29Z","timestamp":1435036289000},"page":"903-909","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["miR-448 negatively regulates ovarian cancer cell growth and metastasis by targeting CXCL12"],"prefix":"10.1007","volume":"17","author":[{"given":"Y.","family":"Lv","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,24]]},"reference":[{"key":"1325_CR1","unstructured":"Jayson GC, Kohn EC, Kitchener HC, Ledermann JA. Ovarian cancer. Lancet. 2014, pii:S0140-6736(13)62146-7."},{"key":"1325_CR2","first-page":"465","volume":"8","author":"AN Vargas","year":"2014","unstructured":"Vargas AN. Natural history of ovarian cancer. Ecancermedicalscience. 2014;8:465.","journal-title":"Natural history of ovarian cancer. Ecancermedicalscience."},{"key":"1325_CR3","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","volume":"6","author":"GA Calin","year":"2006","unstructured":"Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6:857\u201366.","journal-title":"Nat Rev Cancer"},{"key":"1325_CR4","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrc1840","volume":"6","author":"A Esquela-Kerscher","year":"2006","unstructured":"Esquela-Kerscher A, Slack FJ. Oncomirs\u2014microRNAs with a role in cancer. Nat Rev Cancer. 2006;6:259\u201369.","journal-title":"Nat Rev Cancer"},{"key":"1325_CR5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3389\/fonc.2014.00143","volume":"4","author":"Y Wang","year":"2014","unstructured":"Wang Y, Kim S, Kim IM. Regulation of metastasis by microRNAs in ovarian cancer. Front Oncol. 2014;4:143.","journal-title":"Front Oncol."},{"issue":"1","key":"1325_CR6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.artmed.2014.06.003","volume":"62","author":"S Kim","year":"2014","unstructured":"Kim S, Park T, Kon M. Cancer survival classification using integrated data sets and intermediate information. Artif Intell Med. 2014;62(1):23\u201331.","journal-title":"Artif Intell Med"},{"issue":"1","key":"1325_CR7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/cdd.2010.103","volume":"18","author":"QQ Li","year":"2011","unstructured":"Li QQ, Chen ZQ, Cao XX, Xu JD, Xu JW, Chen YY, et al. Involvement of NF-\u03baB\/miR-448 regulatory feedback loop in chemotherapy-induced epithelial-mesenchymal transition of breast cancer cells. Cell Death Differ. 2011;18(1):16\u201325.","journal-title":"Cell Death Differ"},{"issue":"10","key":"1325_CR8","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1210\/me.2010-0054","volume":"24","author":"M Kinoshita","year":"2010","unstructured":"Kinoshita M, Ono K, Horie T, Nagao K, Nishi H, Kuwabara Y, et al. Regulation of adipocyte differentiation by activation of serotonin (5-HT) receptors 5-HT2AR and 5-HT2CR and involvement of microRNA-448-mediated repression of KLF5. Mol Endocrinol. 2010;24(10):1978\u201387.","journal-title":"Mol Endocrinol"},{"key":"1325_CR9","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.exphem.2006.04.002","volume":"34","author":"A Dar","year":"2006","unstructured":"Dar A, Kollet O, Lapidot T. Mutual, reciprocal SDF-1\/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD\/SCID chimeric mice. Exp Hematol. 2006;34:967\u201375.","journal-title":"Exp Hematol"},{"issue":"4","key":"1325_CR10","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s10555-010-9256-x","volume":"29","author":"X Sun","year":"2010","unstructured":"Sun X, Cheng G, Hao M, Zheng J, Zhou X, Zhang J, et al. CXCL12\/CXCR4\/CXCR7 chemokine axis and cancer progression. Cancer metastasis Rev. 2010;29(4):709\u201322.","journal-title":"Cancer metastasis Rev"},{"issue":"11","key":"1325_CR11","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1158\/1078-0432.CCR-09-2329","volume":"16","author":"BA Teicher","year":"2010","unstructured":"Teicher BA, Fricker SP. CXCL12 (SDF-1)\/CXCR4 pathway in cancer. Clin Cancer Res. 2010;16(11):2927\u201331.","journal-title":"Clin Cancer Res"},{"issue":"1\u20132","key":"1325_CR12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11010-013-1671-1","volume":"380","author":"B Xue","year":"2013","unstructured":"Xue B, Wu W, Huang K, Xie T, Xu X, Zhang H, et al. Stromal cell-derived factor-1 (SDF-1) enhances cells invasion by \u03b1v\u03b26 integrin-mediated signaling in ovarian cancer. Mol Cell Biochem. 2013;380(1\u20132):177\u201384.","journal-title":"Mol Cell Biochem"},{"issue":"7","key":"1325_CR13","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/bjc.2012.49","volume":"106","author":"A Popple","year":"2012","unstructured":"Popple A, Durrant LG, Spendlove I, Rolland P, Scott IV, Deen S, et al. The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer. Br J Cancer. 2012;106(7):1306\u201313.","journal-title":"Br J Cancer"},{"issue":"3","key":"1325_CR14","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ijc.25619","volume":"128","author":"R Lis","year":"2011","unstructured":"Lis R, Touboul C, Mirshahi P, Ali F, Mathew S, Nolan DJ, et al. Tumor associated mesenchymal stem cells protects ovarian cancer cells from hyperthermia through CXCL12. Int J Cancer. 2011;128(3):715\u201325.","journal-title":"Int J Cancer"},{"key":"1325_CR15","doi-asserted-by":"crossref","first-page":"249393","DOI":"10.1155\/2014\/249393","volume":"2014","author":"Y Kinose","year":"2014","unstructured":"Kinose Y, Sawada K, Nakamura K, Kimura T. The role of microRNAs in ovarian cancer. Biomed Res Int. 2014;2014:249393.","journal-title":"Biomed Res Int."},{"key":"1325_CR16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2162-3619-3-14","volume":"3","author":"YN Zhao","year":"2014","unstructured":"Zhao YN, Chen GS, Hong SJ. Circulating MicroRNAs in gynecological malignancies: from detection to prediction. Exp Hematol Oncol. 2014;3:14.","journal-title":"Exp Hematol Oncol."},{"issue":"2","key":"1325_CR17","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3390\/ijms12020983","volume":"12","author":"MJ Kwon","year":"2011","unstructured":"Kwon MJ, Shin YK. Epigenetic regulation of cancer-associated genes in ovarian cancer. Int J Mol Sci. 2011;12(2):983\u20131008.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1325_CR18","doi-asserted-by":"crossref","first-page":"F77","DOI":"10.1677\/ERC-09-0203","volume":"17","author":"N Dahiya","year":"2010","unstructured":"Dahiya N, Morin PJ. MicroRNAs in ovarian carcinomas. Endocr Relat Cancer. 2010;17(1):F77\u201389.","journal-title":"Endocr Relat Cancer"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-015-1325-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-015-1325-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-015-1325-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:51:44Z","timestamp":1559433104000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-015-1325-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,24]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["1325"],"URL":"https:\/\/doi.org\/10.1007\/s12094-015-1325-8","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,24]]}}}